Similarly, several studies used CNN and/or RF models to predict molecular markers (such as TERT (61), 7/10 aneuploidies, CDKN2 family mutations (66), receptor tyrosine kinase II (RTKII) (67), and tumor proliferation marker (Ki-67) (63) in glioma patients’ MRI and reached a high degree of accuracy. Here, MKI67 is linked to neoplasm.